Primary record
1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-; (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide; Brivaracetam; Briviact; UCB 34714
- 库存
- 7,781 克
- 纯度
- 99.4 %
- CAS
- 357336-20-0
化合物标识与属性
- CAS
- 357336-20-0
- PubChem CID
- 9837243
- SMILES
- CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N
- Canonical SMILES
- CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1
名称与同义词
- Brivaracetam
- Briviact
- Rikelta
- brivaracetamum
- Brivaracetam?
- 357336-20-0
- compound 83alpha
- (R)-Atomoxetine
- Briviact (TN)
- UCB 34714
- UCB-34714
- U863JGG2IA
- UCB34714
- Brivaracetam (Racemate)
- Brivaracetam [USAN:INN]
- RefChem:57048
- UNII-U863JGG2IA
- BRIVARACETAM [MI]
- Brivaracetam (USAN/INN)
- BRIVARACETAM [INN]
- BRIVARACETAM [JAN]
- D0CT4D
- BRIVARACETAM [USAN]
- Brivaracetam [EP monograph]
- BRIVARACETAM [MART.]
- orb363926
- BRIVARACETAM [WHO-DD]
- SCHEMBL122081
- CHEBI:133013
- DTXSID00905081
- MFCD25976668
- 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide
- Brivaracetam (JAN/USAN/INN)
- C11H20N2O2
- CHEMBL607400
- GTPL9041
- AE5 - Anti-epileptic drugs 5
- (2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
- N03AX23
- DEA NO. 2710
- MSYKRHVOOPPJKU-BDAKNGLRSA-N
- BRIVARACETAM [ORANGE BOOK]
- DTXCID601334183
- GLXC-27574
- EX-A2748
- ZINC3979899
- BDBM50422531
- AKOS027324306
- ACN-055569
- CCG-266666
- CID9837243
- CS-3418
- DB05541
- CID:9837243
- NCGC00390779-02
- AC-29289
- AN-16688
- AS-35277
- BB161996
- HY-14449
- 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-
- SID:134223655
- NS00068020
- J2.411.659J
- (2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide
- D08879
- (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide
- C482793
- Q408099
- (2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butanamide
- 2(s)-[2-oxo-4(r)-propylpyrrolidin-1-yl]butyramide
- A1182302
- (2s)-2-[(4r)-2-oxo-4-propylpyrrolidinyl]butanamide
- (S)-2-(4beta-Propyl-2-oxo-1-pyrrolidinyl)butanamide
- BRD-K00634421-001-01-0
- (2S)-2-((4R)-2-oxo-4-n-propyl-1-pyrrolidinyl)butanamide
- (2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide
- (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
- (2S)-2-[(4R)-2-oxidanylidene-4-propyl-pyrrolidin-1-yl]butanamide
- (alpha S,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-
- (2S)-2-((4R)-2-OXO-4-PROPYLTETRAHYDRO-1H-PYRROL-1-YL) BUTANAMIDE
- 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-; (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide; Brivaracetam; Briviact; UCB 34714
- 357335-87-6
- 83015-26-3
- VLX